Cargando…

Corrigendum: The effects of pemafibrate and Omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, parallel group trial in Japan (PROUD48 study)

Detalles Bibliográficos
Autores principales:	Takeda, Yasutaka, Sakuma, Ichiro, Hiramitsu, Shinya, Okada, Mizuho, Ueda, Shinichiro, Sakurai, Masaru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061344/ https://www.ncbi.nlm.nih.gov/pubmed/37008309 http://dx.doi.org/10.3389/fcvm.2023.1172664

Ejemplares similares

The effects of pemafibrate and omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, parallel group trial in Japan (PROUD48 study)
por: Takeda, Yasutaka, et al.
Publicado: (2023)

Study protocol of the PROUD48 study comparing the effects of pemafibrate and omega-3 fatty acid ethyl esters on ApoB-48 in statin-treated patients with dyslipidaemia: a prospective, multicentre, open-label, randomised, parallel group trial in Japan
por: Takeda, Yasutaka, et al.
Publicado: (2022)

Investigation of human apoB48 metabolism using a new, integrated non‐steady‐state model of apoB48 and apoB100 kinetics
por: Björnson, E., et al.
Publicado: (2019)

ApoB48 as an Efficient Regulator of Intestinal Lipid Transport
por: Lo, Chunmin C., et al.
Publicado: (2020)

ApoB48-Lipoproteins Are Associated with Cardiometabolic Risk in Adolescents with and without Polycystic Ovary Syndrome
por: Vine, Donna F, et al.
Publicado: (2020)

Potential role of ATM in hepatocyte endocytosis of ApoE-deficient, ApoB48-containing lipoprotein in ApoE-deficient mice
por: WU, JIANHUA, et al.
Publicado: (2014)

Chylomicrons produced by Caco‐2 cells contained ApoB‐48 with diameter of 80–200 nm
por: Nauli, Andromeda M., et al.
Publicado: (2014)

Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome
por: Meyers, Charles Daniel, et al.
Publicado: (2015)

The elevation of plasma concentrations of apoB-48-containing lipoproteins in familial hypercholesterolemia is independent of PCSK9 levels
por: Drouin-Chartier, Jean-Philippe, et al.
Publicado: (2017)

Effect of 48‐week pemafibrate on non‐alcoholic fatty liver disease with hypertriglyceridemia, as evaluated by the FibroScan‐aspartate aminotransferase score
por: Hatanaka, Takeshi, et al.
Publicado: (2021)

Regulation of plasma LDL: the apoB paradigm
por: Sniderman, Allan D., et al.
Publicado: (2009)

Effect of Pitavastatin Treatment on ApoB-48 and Lp-PLA(2) in Patients with Metabolic Syndrome: Substudy of PROspective Comparative Clinical Study Evaluating the Efficacy and Safety of PITavastatin in Patients with Metabolic Syndrome
por: Lee, Hyo-Sun, et al.
Publicado: (2016)

This proud heart
por: Buck, Pearl S. (Pearl Sydenstricker), 1892-1973
Publicado: (1943)

Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator (SPPARMα): Pooled Analysis of Phase 2 and 3 Studies in Dyslipidemic Patients with or without Statin Combination
por: Yamashita, Shizuya, et al.
Publicado: (2019)

The Link between Magnesium Supplements and Statin Medication in Dyslipidemic Patients
por: Nartea, Roxana, et al.
Publicado: (2023)

Long-term risk of a major cardiovascular event by apoB, apoA-1, and the apoB/apoA-1 ratio—Experience from the Swedish AMORIS cohort: A cohort study
por: Walldius, Göran, et al.
Publicado: (2021)

A Comparison of Lipids and apoB in Asian Indians and Americans
por: Singh, Kavita, et al.
Publicado: (2021)

NA48
por: Fry, J
Publicado: (1995)

CCM no. 48
Publicado: (1978)

Antibodies against apoB100 peptide 210 inhibit atherosclerosis in apoE(-/-) mice
por: Dunér, Pontus, et al.
Publicado: (2021)

Latest Results from NA48 and NA48/1
por: Slater, Mark W.
Publicado: (2004)

Memorandum: Status reports of the NA48 and NA48/1
por: Ceccucci, Augusto, et al.
Publicado: (2001)

HBV inhibits apoB production via the suppression of MTP expression
por: Wang, Fu-Bing, et al.
Publicado: (2011)

SAA is Found on ApoB-Containing Lipoproteins in Obese Diabetic Humans
por: Jahangiri, Anisa, et al.
Publicado: (2013)

Serum ApoB levels in depressive patients: associated with cognitive deficits
por: Hui, Li, et al.
Publicado: (2017)

ApoB-Specific CD4(+) T Cells in Mouse and Human Atherosclerosis
por: Marchini, Timoteo, et al.
Publicado: (2021)

Comparison of efficacy, safety, and cost-effectiveness of various statins in dyslipidemic diabetic patients
por: Bener, Abdulbari, et al.
Publicado: (2014)

Thyroid volumes and serum VEGF levels in dyslipidemic patients: effects of statin treatment
por: AYDIN, Kadriye, et al.
Publicado: (2019)

Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment
por: Yokote, Koutaro, et al.
Publicado: (2019)

Distinct Differences in Lipoprotein Particle Number Evaluation between GP-HPLC and NMR: Analysis in Dyslipidemic Patients Administered a Selective PPARα Modulator, Pemafibrate
por: Yamashita, Shizuya, et al.
Publicado: (2021)

Status report on the experiments NA48/1 and NA48/2
por: Kekelidze, Vladimir D, et al.
Publicado: (2005)

Biosynthesis of lipoprotein: location of nascent apoAI and apoB in the rough endoplasmic reticulum of chicken hepatocytes
Publicado: (1992)

Human apoB contributes to increased serum total apo(a) level in LPA transgenic mice
por: Teivainen, Päivi A, et al.
Publicado: (2004)

Coalition of DNA polymorphisms of ApoB and ApoAI genes is related with coronary artery disease in Kazaks
por: Huang, Gang, et al.
Publicado: (2012)

ApoB/apoA1 is an effective predictor of coronary heart disease risk in overweight and obesity()
por: Lu, Min, et al.
Publicado: (2011)

Sushrutha - our proud heritage
por: Bhattacharya, Surajit
Publicado: (2009)

We are proud of you Jamie
por: Azoulay, Elie, et al.
Publicado: (2022)

“PROUD to have been involved”: an evaluation of participant and community involvement in the PROUD HIV prevention trial
por: Gafos, Mitzy, et al.
Publicado: (2020)

NA48 results
por: Ruggiero, G
Publicado: (2008)

Requiem, op. 48
por: Fauré, Gabriel, 1845-1924
Publicado: (1986)

Cannot write session to /tmp/vufind_sessions/sess_rh4qaqqnitp3m7m8tm3q7pc50k